PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.27%
Net income growth under 50% of ORCL's 51.73%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-4.31%
Both reduce yoy D&A, with ORCL at -2.43%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
652.54%
Well above ORCL's 19.39% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
0.55%
SBC growth while ORCL is negative at -1.55%. John Neff would see competitor possibly controlling share issuance more tightly.
-303.71%
Both reduce yoy usage, with ORCL at -76.39%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-261.20%
AR is negative yoy while ORCL is 90.05%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-78.24%
Negative yoy inventory while ORCL is 44.12%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
674.51%
AP growth well above ORCL's 448.76%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-2062.86%
Both reduce yoy usage, with ORCL at -95.07%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
875.05%
Well above ORCL's 382.22%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-31.48%
Negative yoy CFO while ORCL is 41.14%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
2.43%
Lower CapEx growth vs. ORCL's 41.35%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
98.60%
Acquisition spending well above ORCL's 79.93%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
42.43%
Some yoy expansion while ORCL is negative at -34.48%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
12.70%
We have some liquidation growth while ORCL is negative at -0.56%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-3421.88%
Both yoy lines negative, with ORCL at -76.47%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
86.69%
We have mild expansions while ORCL is negative at -140.60%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-975.27%
We cut debt repayment yoy while ORCL is 48.96%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-260.21%
Negative yoy issuance while ORCL is 18.37%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-48.11%
Both yoy lines negative, with ORCL at -67.76%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.